News Tag: Evan Powers

FDA approves Scripps Research-originated drug tafamidis for cardiomyopathy

The U.S. Food and Drug Administration has approved tafamidis for the treatment of heart disease (cardiomyopathy) caused by mutant or wild-type transthyretin aggregation in adults.